STOCK TITAN

Radnet - RDNT STOCK NEWS

Welcome to our dedicated page for Radnet news (Ticker: RDNT), a resource for investors and traders seeking the latest updates and insights on Radnet stock.

RadNet Inc (NASDAQ: RDNT) operates one of the largest networks of outpatient diagnostic imaging centers in the U.S., combining advanced medical imaging services with AI-powered health informatics solutions. This news hub provides investors and healthcare professionals with essential updates on the company's financial performance, technological advancements, and strategic initiatives.

Access authoritative reporting on quarterly earnings, partnership announcements, and innovations in radiology workflow optimization. Our curated collection features official press releases alongside third-party analysis of RadNet's Imaging Center operations and DeepHealth digital solutions.

Key updates include developments in AI-enhanced diagnostic tools, imaging center expansions, and regulatory milestones. Track how RDNT integrates cloud-native platforms with traditional radiology services to improve patient outcomes and operational efficiency.

Bookmark this page for continuous access to verified information about RadNet's market position. Check regularly for updates on service enhancements, financial disclosures, and leadership insights shaping the future of diagnostic imaging.

Rhea-AI Summary

RadNet (RDNT) reported a robust second quarter of 2021, with revenue soaring 75.2% to a record $333.9 million, up from $190.6 million in Q2 2020. Adjusted EBITDA rose 150.7% to $56.6 million. The company also achieved an adjusted EPS of $0.27, contrasting with a loss of $(0.14) per share in the previous year. Total procedural volumes surged 92.7%, driven by significant increases in MRI and CT volumes. RadNet upgraded its 2021 guidance, anticipating higher revenue, adjusted EBITDA, and free cash flow, while preparing for potential impacts from COVID-19 variants.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.31%
Tags
-
Rhea-AI Summary

RadNet, Inc. (NASDAQ: RDNT) will host a conference call on August 9, 2021, at 7:30 a.m. PT to discuss its Q2 2021 financial results. Investors can participate by calling 888-394-8218 or 646-828-8193 for international access, with webcasts available for listening. RadNet operates 346 outpatient imaging centers and employs approximately 8,300 people across several states. This conference call signifies the company's transparency and commitment to keeping investors informed about its financial performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.52%
Tags
-
Rhea-AI Summary

RadNet, a leader in diagnostic imaging, announced that Greg Sorensen from its DeepHealth AI division will speak with Jefferies equity research analysts on June 30, 2021, at 1:00 p.m. ET. This call underscores RadNet's commitment to integrating artificial intelligence in its services. Interested participants can register for the live webcast or access the archived version via the provided link. RadNet operates 346 outpatient imaging centers across the U.S., employing about 8,300 staff in states including California and New York.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.22%
Tags
conferences
Rhea-AI Summary

RadNet, a leader in diagnostic imaging services, announced that Mark Stolper, CFO, will present at the Jefferies 2021 Virtual Global Healthcare Conference on June 3, 2021, at 2:30 p.m. Eastern Time. The event will feature a webcast accessible at RadNet's website and through the Jefferies platform.

RadNet operates 346 outpatient imaging centers across several states, employing around 8,300 individuals. The company is recognized for its extensive market presence and annual imaging revenue in the U.S.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.24%
Tags
conferences
-
Rhea-AI Summary

RadNet reported a 12% revenue increase to $315.3 million for Q1 2021 compared to Q1 2020. Adjusted EBITDA rose 123.4% to $45.5 million, while diluted net income per share improved to $0.18 from a loss of $(0.33) year-over-year. Procedural volumes grew 8.4% overall, with same-center volume increasing 5%. The company received FDA clearance for its DeepHealth AI mammography software and successfully refinanced its senior credit facilities, anticipating interest savings of up to $6 million. Full-year 2021 guidance was revised upwards for revenue, adjusted EBITDA, and free cash flow.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.02%
Tags
-
Rhea-AI Summary

eRAD, a subsidiary of RadNet (NASDAQ: RDNT), announced the successful deployment of its Radiology Information System (RIS) by Shields Health Care Group across multiple imaging locations in New England. The collaboration enhances operational efficiency and patient experience through features like automated patient communication and digital forms for scheduling. Shields sought a flexible partner to accommodate diverse workflow needs, and the eRAD system aims to improve training for staff, allowing more focus on patient care. This implementation underscores eRAD's adaptability and commitment to advancing imaging services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.42%
Tags
none
Rhea-AI Summary

RadNet, Inc. (NASDAQ: RDNT) announced a conference call on May 10, 2021, at 7:30 a.m. PT to discuss its Q1 2021 financial results. Investors can join by calling 800-437-2398 (international: 929-477-0577). A web replay will also be available. As a leader in diagnostic imaging, RadNet operates 331 outpatient imaging centers across key markets including California and New York, employing approximately 8,300 staff. The call will provide insights into the company's financial performance and future outlook.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.3%
Tags
-
Rhea-AI Summary

RadNet announced the successful refinancing of its senior secured term loan and revolving credit facilities, totaling $725 million and $195 million, respectively. This refinancing reduces the interest rate margin from 3.75% to 3.25% and extends the maturity date to April 2028 for term loans and April 2026 for revolving credit. The refinancing allows RadNet to reduce borrowing costs, increase operational flexibility, and add $107 million to its balance sheet.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.27%
Tags
none
-
Rhea-AI Summary

RadNet, Inc. (NASDAQ: RDNT) announced FDA clearance for its AI-driven mammography triage software, Saige-Q. This tool enhances radiologists' efficiency by prioritizing suspicious screening exams, supporting both 2D and 3D mammography. Saige-Q is pivotal for DeepHealth, marking its first FDA-cleared product and aims to improve care efficiency. With nearly 2 million mammography exams performed annually, RadNet plans to deploy the technology to boost accuracy and productivity in radiology, reflecting its commitment to AI in healthcare transformation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.11%
Tags
none
Rhea-AI Summary

RadNet, Inc. (NASDAQ: RDNT) announced a proposed refinancing of its existing senior secured term loan, amounting to $611 million, and a $195 million revolving credit facility. The plan includes a new seven-year $675 million term loan B facility and a five-year $195 million revolving credit facility. The refinancing aims to lower costs and extend maturities. However, completion is subject to market conditions and negotiations with lenders, with no guarantee of favorable terms. RadNet operates 331 imaging centers across the U.S., employing around 8,300 personnel.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.72%
Tags
none
Radnet

Nasdaq:RDNT

RDNT Rankings

RDNT Stock Data

3.69B
65.94M
10.43%
88.78%
7.66%
Diagnostics & Research
Services-medical Laboratories
Link
United States
LOS ANGELES